Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Cutan Pathol ; 48(7): 863-869, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33486806

ABSTRACT

BACKGROUND: Pyogenic granuloma (PG) is a lesion characterized by the proliferation of blood vessels, commonly affecting the skin and the mouth. We aimed to compare clinical, microscopic, and immunohistochemical features of the two types of oral PG: lobular capillary hemangioma (LCH) and non-LCH (NLCH). METHODS: Epidemiological and clinical data from 2000 to 2018 were collected from the archives of our institution, and histopathological sections of PG were reviewed. Immunohistochemical analyses (CD34, D2-40, SMA, mast cell, and Ki-67) were performed in 34 cases. RESULTS: Sixty-two LCH and 107 non-LCH samples were included. The mean (±SD) age of the patients was 38.59 ± 16.96 years; 55.62% were female; 39.64% of cases occurred in the gingiva, 44% of the nodules were pedunculated, and 13.02% of patients reported a history of trauma. NLCH was more prevalent among older patients than LCH. The most prevalent site of LCH was the lips, while NLCH occurred more in the gingiva (P < 0.05). Epithelial atrophy, microvessels, SMA-positive areas, and Ki-67-positive nuclei were more prevalent in LCH (P < 0.05). CONCLUSIONS: PG accounted for 2.25% of lesions archived in the pathology service and most cases were NLCH. LCH and NLCH exhibited clinicopathological differences in terms of age, site, epithelial atrophy, vascularization, and proliferation rate.


Subject(s)
Granuloma, Pyogenic/diagnosis , Granuloma, Pyogenic/metabolism , Mouth Mucosa/pathology , Neovascularization, Pathologic/pathology , Actins/metabolism , Adult , Biopsy , Case-Control Studies , Female , Gingiva/pathology , Granuloma, Pyogenic/epidemiology , Granuloma, Pyogenic/pathology , Humans , Immunohistochemistry/methods , Ki-67 Antigen/metabolism , Lip/pathology , Male , Middle Aged , Mouth/pathology , Mouth Mucosa/blood supply , Mouth Mucosa/ultrastructure , Prevalence , Retrospective Studies
2.
Arch Oral Biol ; 119: 104894, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32950917

ABSTRACT

OBJECTIVE: Lactobacillus reuteri is reported as a beneficial adjunct to conventional periodontitis treatment or as monotherapy for gingivitis in several clinical trials. However, probiotics are not free from the risk of adverse effects. We investigated the effects of live and heat-killed (paraprobiotic) L. reuteri during the development of ligature-induced periodontitis in rats. METHODS: Thirty-two male rats were divided into four groups-control group: healthy rats, LIP group: rats with ligature induced periodontitis, LIP/PRO group: rats with periodontitis that received live L. reuteri, LIP/PARA group: rats with periodontitis that received heat-killed L. reuteri. Treatment was administered for 30 days prior to ligation and continued for 14 days until euthanasia. The hemimandibles were removed and submitted to radiographic analysis, microcomputerized microtomography (µCT) and histomorphometric analysis. RESULTS: Radiographic analysis revealed that pro- and paraprobiotics enhanced the percentage of mesial bone support. The µCT analysis showed that paraprobiotic treatment increased bone volume and trabecular number while decreasing total bone porosity and trabecular separation. Live probiotic led to higher trabecular thickness. In the histomorphometric analysis, paraprobiotics significantly prevented furcation bone loss and collagen breakdown, although both pro- and paraprobiotics similarly reduced mesial bone loss. There were no significant differences in attachment loss or the number of tartrate-resistant acid phosphatase -positive cells across treatments. CONCLUSIONS: Although viable and heat-killed bacteria reduced mesial alveolar bone loss and ameliorated furcation microarchitecture parameters, paraprobiotics presented the most pronounced results preventing periodontitis development. This can contribute to the future use of paraprobiotics in the prevention and treatment of periodontitis.


Subject(s)
Alveolar Bone Loss , Limosilactobacillus reuteri , Periodontitis , Probiotics/therapeutic use , Alveolar Bone Loss/prevention & control , Animals , Hot Temperature , Male , Periodontitis/prevention & control , Rats
3.
Bone ; 83: 241-247, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26620086

ABSTRACT

Periodontal pathogens and/or inflammatory products from periodontitis participate in the development or progression of systemic diseases. In this context, periodontitis acts as a modifying factor to systemic health, including diabetes and cardiovascular diseases. Osteoporosis is an increasingly prevalent condition in our aging population and considered a risk factor for periodontal disease, but the effect of periodontitis on systemic bone homeostasis is unknown. We thus evaluated the effects of experimental periodontitis (EP) on systemic bone loss and the influence of estrogen deficiency in this context, using a mouse model of combined periodontitis and osteoporosis. Experimental periodontitis (EP) was induced by a ligature insertion around the mandibular first molars and Porphyromonas gingivalis infection. Three-dimensional microcomputed tomographic analyses performed 48days following infection revealed that EP and ovariectomy (OVX) induced a significantly higher femoral and mandibular bone loss compared to EP or OVX alone. EP alone did not induce systemic bone loss. In addition, the EP+OVX and EP groups showed significantly higher levels of tumor necrosis factor (TNF)-α than OVX and control groups at end point. These results suggest that periodontitis could be a risk factor for systemic bone loss, especially in post-menopausal women, and warrant further clinical investigations to confirm this association and propose adapted prophylactic and curative therapies.


Subject(s)
Bone Resorption/etiology , Bone Resorption/pathology , Disease Progression , Ovariectomy/adverse effects , Periodontal Diseases/complications , Periodontal Diseases/pathology , Animals , Body Weight , Collagen Type I/blood , Collagen Type I/urine , Cytokines/blood , Cytokines/urine , Dental Cementum/pathology , Dental Enamel/pathology , Female , Femur/diagnostic imaging , Femur/pathology , Mandible/diagnostic imaging , Mandible/pathology , Mice, Inbred BALB C , Osteocalcin/blood , Osteocalcin/urine , Peptides/blood , Peptides/urine , Tumor Necrosis Factor-alpha/blood , Tumor Necrosis Factor-alpha/urine , X-Ray Microtomography
4.
J Periodontol ; 86(11): 1287-95, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26205746

ABSTRACT

BACKGROUND: New drugs for the treatment of diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists and inhibitors of dipeptidyl peptidase-4 (DPP-4) have shown pleiotropic effects on bone metabolism and anti-inflammatory properties. The aim of this study is to evaluate the effects of exenatide (GLP-1 agonist) and sitagliptin (DPP-4 inhibitor) during periodontitis induction by ligature insertion in rats. METHODS: Forty rats were divided into four groups: 1) animals with induced periodontitis that received exenatide (EG); 2) animals with induced periodontitis that received sitagliptin (SG); 3) animals with induced periodontitis and without drug treatment (LG); and 4) animals without induced periodontitis and without drug treatment (controls). The drugs were administered for 28 days. On the day the animals were sacrificed, blood was collected for analysis of glucose and DPP-4 levels. The gene expressions of prostaglandin-endoperoxide synthase 2, tissue inhibitor of metalloproteinase 1, Dpp4, nitric oxide synthase 2 (Nos2), interleukin 1ß (Il1b), and matrix metalloproteinase 9 (Mmp9) in the gingiva; support and alveolar bone loss; connective tissue attachment; and the quantity of gingival collagen were evaluated. RESULTS: Exenatide and sitagliptin treatments have led to a lower percentage of weight gain but did not influence glycemia. Sitagliptin reduced the serum concentration of DPP-4. Interestingly, although the gene expression profile has revealed a downregulation of Mmp9, Nos2, and Il1b in both EG and SG compared to LG, a significant protective effect was not observed on alveolar bone and collagen tissue in this model. CONCLUSION: Regardless of the reduction of the expression of Il1b, Nos2, and Mmp9, the drugs were not effective in the stabilization or reduction of alveolar bone loss and collagen degradation in rats.


Subject(s)
Alveolar Bone Loss , Hypoglycemic Agents/pharmacology , Peptides/pharmacology , Periodontitis , Sitagliptin Phosphate/pharmacology , Venoms/pharmacology , Animals , Exenatide , Interleukin-1beta/metabolism , Matrix Metalloproteinase 9 , Nitric Oxide Synthase Type II/metabolism , Rats , Tissue Inhibitor of Metalloproteinase-1/metabolism
5.
Pathol Res Pract ; 211(2): 125-9, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25532670

ABSTRACT

In order to standardize an experimental model to study the effects of absence of ovarian hormones in maxillary bones compared with long bones, the aim of this research was to analyze the influence of ovariectomy (OVX) on rat alveolar bone and tibiae, in different observation periods. Thirty-six female rats were ovariectomized or sham operated. After 60, 90 or 120 days, the animals were sacrificed and their hemimandibles, maxillae and tibiae were removed and routinely prepared for hematoxylin and eosin staining. The percentage of bone matrix area in bone septum in the first molar furcation region, and in tibial metaphysis was calculated, and data were submitted to statistical analysis (p<0.05). As regards the histomorphometrical analysis in jaw bones, there was no statistical difference between groups, while the effects of ovariectomy on tibiae were seen as early as 60 days. According to the methods used, there was no significant influence of absence of ovarian hormones on interradicular septum of mandibular or maxillary first molars in the periods studied, despite the reduction in bone matrix area in tibia metaphysis as early as 60 days.


Subject(s)
Bone Matrix/physiopathology , Bone Remodeling , Mandible/physiopathology , Maxilla/physiopathology , Ovariectomy , Tibia/physiopathology , Animals , Female , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...